| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |